Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 17891 | 514 | 48.3 | 90% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PU1 | Author keyword | 47 | 39% | 18% | 94 |
| 2 | SPI 1 PU1 | Author keyword | 3 | 57% | 1% | 4 |
| 3 | SFPI1 PU1 | Author keyword | 3 | 100% | 1% | 3 |
| 4 | RADIATION INDUCED AML | Author keyword | 2 | 67% | 0% | 2 |
| 5 | SPI 1 | Author keyword | 2 | 25% | 1% | 7 |
| 6 | SFFV | Author keyword | 1 | 38% | 1% | 3 |
| 7 | SPI B | Author keyword | 1 | 38% | 1% | 3 |
| 8 | MED HEMATOL 1 | Address | 1 | 50% | 0% | 2 |
| 9 | MURINE ERYTHROLEUKEMIA | Author keyword | 1 | 25% | 1% | 3 |
| 10 | BIOL EFFECTS | Address | 1 | 21% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | PU1 | 47 | 39% | 18% | 94 | Search PU1 | Search PU1 |
| 2 | SPI 1 PU1 | 3 | 57% | 1% | 4 | Search SPI+1+PU1 | Search SPI+1+PU1 |
| 3 | SFPI1 PU1 | 3 | 100% | 1% | 3 | Search SFPI1+PU1 | Search SFPI1+PU1 |
| 4 | RADIATION INDUCED AML | 2 | 67% | 0% | 2 | Search RADIATION+INDUCED+AML | Search RADIATION+INDUCED+AML |
| 5 | SPI 1 | 2 | 25% | 1% | 7 | Search SPI+1 | Search SPI+1 |
| 6 | SFFV | 1 | 38% | 1% | 3 | Search SFFV | Search SFFV |
| 7 | SPI B | 1 | 38% | 1% | 3 | Search SPI+B | Search SPI+B |
| 8 | MURINE ERYTHROLEUKEMIA | 1 | 25% | 1% | 3 | Search MURINE+ERYTHROLEUKEMIA | Search MURINE+ERYTHROLEUKEMIA |
| 9 | CD11C INTEGRIN | 1 | 50% | 0% | 1 | Search CD11C+INTEGRIN | Search CD11C+INTEGRIN |
| 10 | DNA BINDING SITE SELECTION | 1 | 50% | 0% | 1 | Search DNA+BINDING+SITE+SELECTION | Search DNA+BINDING+SITE+SELECTION |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TRANSCRIPTION FACTOR PU1 | 66 | 38% | 27% | 138 |
| 2 | ETS ONCOGENE | 28 | 51% | 8% | 39 |
| 3 | SPI 1 PU1 | 13 | 69% | 2% | 11 |
| 4 | CD11B PROMOTER | 12 | 40% | 5% | 24 |
| 5 | ERYTHROLEUKEMIAS | 10 | 61% | 2% | 11 |
| 6 | ETS PROTEIN | 9 | 55% | 2% | 12 |
| 7 | PUTATIVE ONCOGENE SPI 1 | 9 | 43% | 3% | 16 |
| 8 | FRIEND ERYTHROLEUKEMIA | 7 | 46% | 2% | 11 |
| 9 | FACTOR SPI 1 PU1 | 6 | 100% | 1% | 4 |
| 10 | PU1 REGULATES EXPRESSION | 4 | 47% | 1% | 7 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis | 2010 | 31 | 104 | 48% |
| Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis? | 2007 | 30 | 54 | 56% |
| The Transcription Factor PU.1 is a Critical Regulator of Cellular Communication in the Immune System | 2011 | 10 | 99 | 60% |
| The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages | 1999 | 88 | 82 | 70% |
| PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis | 2009 | 15 | 116 | 45% |
| PU.1 downregulation in murine radiation-induced acute myeloid leukaemia (AML): from molecular mechanism to human AML | 2015 | 0 | 63 | 76% |
| Epigenetic control of hematopoiesis: the PU.1 chromatin connection | 2014 | 1 | 74 | 45% |
| Surprising new roles for PU.1 in the adaptive immune response | 2010 | 21 | 110 | 29% |
| Stem cell fate specification: Role of master regulatory switch transcription factor PU.1 in differential hematopoiesis | 2005 | 22 | 85 | 69% |
| Role of PU.1 in hematopoiesis | 1998 | 100 | 93 | 40% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MED HEMATOL 1 | 1 | 50% | 0.4% | 2 |
| 2 | BIOL EFFECTS | 1 | 21% | 0.6% | 3 |
| 3 | CANC CYTOGENETMINAMI KU | 1 | 50% | 0.2% | 1 |
| 4 | CANC GRONINGEN | 1 | 50% | 0.2% | 1 |
| 5 | CELL DIFFERENTIAT OPTOSIS MINISTER ED | 1 | 50% | 0.2% | 1 |
| 6 | FUNDACIO AUGUST PI I SUNYER | 1 | 50% | 0.2% | 1 |
| 7 | HARBIN MED | 1 | 50% | 0.2% | 1 |
| 8 | HUMAN THER Y | 1 | 50% | 0.2% | 1 |
| 9 | IMMUNOL BUNKYO KU | 1 | 50% | 0.2% | 1 |
| 10 | ISL MED | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000232808 | ETS 1//ETS DOMAIN//ETS FAMILY |
| 2 | 0.0000193593 | PAX5//EXPT HEMATOPOIESIS UNIT//EBF |
| 3 | 0.0000161417 | C EBP BETA//C EBP DELTA//C EBP |
| 4 | 0.0000156697 | GATA 1//GATA 2//EDAG |
| 5 | 0.0000123137 | IKAROS//AIOLOS//BCL11B |
| 6 | 0.0000121453 | IRF 1//IRF 2//INTERFERON REGULATORY FACTOR 1 |
| 7 | 0.0000106060 | C FES//FER KINASE//FPS FES |
| 8 | 0.0000082084 | GFI1B//GFI1//ZELLBIOL TUMORFOR |
| 9 | 0.0000081976 | RUNX3//AML1 ETO//AML1 |
| 10 | 0.0000080176 | REACTOR RADIATION//UTR KINKI//LIFE SHORTENING |